References
- FordESCroftJBManninoDMWheatonAGZhangXGilesWHCOPD surveillance – United States, 1999–2011Chest2013144128430523619732
- QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of COPD2016 Available from http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed October 3, 2016
- ThomasPSYatesDHBarnesPJTumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjectsAm J Respir Crit Care Med1995152176807599866
- MichelODinhPHDoyenVCorazzaFAnti-TNF inhibits the airways neutrophilic inflammation induced by inhaled endotoxin in humanBMC Pharmacol Toxicol2014156025371053
- KeatingsVMCollinsPDScottDMBarnesPJDifferences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthmaAm J Respir Crit Care Med199615325305348564092
- AaronSDAngelJBLunauMGranulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2001163234935511179105
- VernooyJHKüçükaycanMJacobsJALocal and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputumAm J Respir Crit Care Med200216691218122412403691
- DaldeganMBTeixeiraMMTalvaniAConcentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbationBraz J Med Biol Res20053891359136516138219
- AntoniuSAMihaltanFUlmeanuRAnti-TNF-alpha therapies in chronic obstructive pulmonary diseasesExpert Opin Investig Drugs200817812031211
- van der VaartHKoëterGHPostmaDSKauffmanHFten HackenNHFirst study of infliximab treatment in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172446546915937294
- RennardSIFogartyCKelsenSThe safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175992693417290043
- SuissaSErnstPHudsonMTNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary diseasePulm Pharmacol Ther200821123423817517530
- AaronSDVandemheenKLMaltaisFTNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trialThorax201368214214823161645
- LitsiouESemitekolouMGalaniIECXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187111194120223525932
- EmeryPSebbaAHuizingaTWBiologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritisAnn Rheum Dis201372121897190423918035
- DentenerMACreutzbergECPenningsHJRijkersGTMerckenEWoutersEFEffect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot studyRespiration200876327528218277064